The Carinthia University of Applied Sciences and the Medical University of Vienna have established a collaboration, supported by the Austrian Science Fund FWF, with the objective of fostering the sustainable interlinking of basic university research and applied brain research. As part of this project, seven doctoral positions will be established with the objective of developing new methods in the fields of ultra-high field magnetic resonance imaging, histology and artificial intelligence. The objective of the research is to advance the treatment of brain tumours and demyelinating diseases such as multiple sclerosis. A novel research platform is being established with the objective of consolidating scientific findings. This initiative will facilitate the integration of scientific expertise and cutting-edge technology from three departments of the Medical University of Vienna: the University Clinics for Radiology and Nuclear Medicine, Neurology, and Neurosurgery; and the Carinthia University of Applied Sciences, which offers programmes in Engineering & IT, Medical Engineering, and Analytics. The objective of this collaborative doctoral programme is, among other things, to identify new clinically relevant biomarkers for neurological diseases through the development of innovative MR imaging methods. These technologies are to be employed in the future as analysis and visualisation tools with a high clinical impact. The collaboration between the Carinthia University of Applied Sciences and the Medical University of Vienna should also facilitate the training of the next generation of scientists, developers and doctors who will be able to utilise these technologies in conjunction with one another in routine clinical practice. One example of this would be the optimisation of neurosurgical planning to better determine the type of tumour, its environment and the simulation of the procedure with the help of virtual reality. In order to meet the highest international standards, the doctoral programme includes at least one stay abroad per doctoral student with international research partners. Seven international renowned cooperation partners from academia (e.g. Harvard and MIT) and industry (e.g. ICOMETRIX) have agreed to host our candidates. In addition to the positive effects for all stakeholders involved in this project, this interdisciplinary and cooperative doctoral programme will also significantly increase the proportion of medical research in Carinthia as the latest findings from Austria's largest medical research institution will be incorporated.

The Carinthia University of Applied Sciences and the Medical University of Vienna have established a collaboration, supported by the Austrian Science Fund FWF, with the objective of fostering the sustainable interlinking of basic university research and applied brain research. As part of this project, seven doctoral positions will be established with the objective of developing new methods in the fields of ultra-high field magnetic resonance imaging, histology and artificial intelligence. The objective of the research is to advance the treatment of brain tumours and demyelinating diseases such as multiple sclerosis. A novel research platform is being established with the objective of consolidating scientific findings. This initiative will facilitate the integration of scientific expertise and cutting-edge technology from three departments of the Medical University of Vienna: the University Clinics for Radiology and Nuclear Medicine, Neurology, and Neurosurgery; and the Carinthia University of Applied Sciences, which offers programmes in Engineering & IT, Medical Engineering, and Analytics. The objective of this collaborative doctoral programme is, among other things, to identify new clinically relevant biomarkers for neurological diseases through the development of innovative MR imaging methods. These technologies are to be employed in the future as analysis and visualisation tools with a high clinical impact. The collaboration between the Carinthia University of Applied Sciences and the Medical University of Vienna should also facilitate the training of the next generation of scientists, developers and doctors who will be able to utilise these technologies in conjunction with one another in routine clinical practice. One example of this would be the optimisation of neurosurgical planning to better determine the type of tumour, its environment and the simulation of the procedure with the help of virtual reality. In order to meet the highest international standards, the doctoral programme includes at least one stay abroad per doctoral student with international research partners. Seven international renowned cooperation partners from academia (e.g. Harvard and MIT) and industry (e.g. ICOMETRIX) have agreed to host our candidates. In addition to the positive effects for all stakeholders involved in this project, this interdisciplinary and cooperative doctoral programme will also significantly increase the proportion of medical research in Carinthia as the latest findings from Austria's largest medical research institution will be incorporated.

The Carinthia University of Applied Sciences and the Medical University of Vienna have established a collaboration, supported by the Austrian Science Fund FWF, with the objective of fostering the sustainable interlinking of basic university research and applied brain research. As part of this project, seven doctoral positions will be established with the objective of developing new methods in the fields of ultra-high field magnetic resonance imaging, histology and artificial intelligence. The objective of the research is to advance the treatment of brain tumours and demyelinating diseases such as multiple sclerosis. A novel research platform is being established with the objective of consolidating scientific findings. This initiative will facilitate the integration of scientific expertise and cutting-edge technology from three departments of the Medical University of Vienna: the University Clinics for Radiology and Nuclear Medicine, Neurology, and Neurosurgery; and the Carinthia University of Applied Sciences, which offers programmes in Engineering & IT, Medical Engineering, and Analytics. The objective of this collaborative doctoral programme is, among other things, to identify new clinically relevant biomarkers for neurological diseases through the development of innovative MR imaging methods. These technologies are to be employed in the future as analysis and visualisation tools with a high clinical impact. The collaboration between the Carinthia University of Applied Sciences and the Medical University of Vienna should also facilitate the training of the next generation of scientists, developers and doctors who will be able to utilise these technologies in conjunction with one another in routine clinical practice. One example of this would be the optimisation of neurosurgical planning to better determine the type of tumour, its environment and the simulation of the procedure with the help of virtual reality. In order to meet the highest international standards, the doctoral programme includes at least one stay abroad per doctoral student with international research partners. Seven international renowned cooperation partners from academia (e.g. Harvard and MIT) and industry (e.g. ICOMETRIX) have agreed to host our candidates. In addition to the positive effects for all stakeholders involved in this project, this interdisciplinary and cooperative doctoral programme will also significantly increase the proportion of medical research in Carinthia as the latest findings from Austria's largest medical research institution will be incorporated.

The Carinthia University of Applied Sciences and the Medical University of Vienna have established a collaboration, supported by the Austrian Science Fund FWF, with the objective of fostering the sustainable interlinking of basic university research and applied brain research. As part of this project, seven doctoral positions will be established with the objective of developing new methods in the fields of ultra-high field magnetic resonance imaging, histology and artificial intelligence. The objective of the research is to advance the treatment of brain tumours and demyelinating diseases such as multiple sclerosis. A novel research platform is being established with the objective of consolidating scientific findings. This initiative will facilitate the integration of scientific expertise and cutting-edge technology from three departments of the Medical University of Vienna: the University Clinics for Radiology and Nuclear Medicine, Neurology, and Neurosurgery; and the Carinthia University of Applied Sciences, which offers programmes in Engineering & IT, Medical Engineering, and Analytics. The objective of this collaborative doctoral programme is, among other things, to identify new clinically relevant biomarkers for neurological diseases through the development of innovative MR imaging methods. These technologies are to be employed in the future as analysis and visualisation tools with a high clinical impact. The collaboration between the Carinthia University of Applied Sciences and the Medical University of Vienna should also facilitate the training of the next generation of scientists, developers and doctors who will be able to utilise these technologies in conjunction with one another in routine clinical practice. One example of this would be the optimisation of neurosurgical planning to better determine the type of tumour, its environment and the simulation of the procedure with the help of virtual reality. In order to meet the highest international standards, the doctoral programme includes at least one stay abroad per doctoral student with international research partners. Seven international renowned cooperation partners from academia (e.g. Harvard and MIT) and industry (e.g. ICOMETRIX) have agreed to host our candidates. In addition to the positive effects for all stakeholders involved in this project, this interdisciplinary and cooperative doctoral programme will also significantly increase the proportion of medical research in Carinthia as the latest findings from Austria's largest medical research institution will be incorporated.

The Carinthia University of Applied Sciences and the Medical University of Vienna have established a collaboration, supported by the Austrian Science Fund FWF, with the objective of fostering the sustainable interlinking of basic university research and applied brain research. As part of this project, seven doctoral positions will be established with the objective of developing new methods in the fields of ultra-high field magnetic resonance imaging, histology and artificial intelligence. The objective of the research is to advance the treatment of brain tumours and demyelinating diseases such as multiple sclerosis. A novel research platform is being established with the objective of consolidating scientific findings. This initiative will facilitate the integration of scientific expertise and cutting-edge technology from three departments of the Medical University of Vienna: the University Clinics for Radiology and Nuclear Medicine, Neurology, and Neurosurgery; and the Carinthia University of Applied Sciences, which offers programmes in Engineering & IT, Medical Engineering, and Analytics. The objective of this collaborative doctoral programme is, among other things, to identify new clinically relevant biomarkers for neurological diseases through the development of innovative MR imaging methods. These technologies are to be employed in the future as analysis and visualisation tools with a high clinical impact. The collaboration between the Carinthia University of Applied Sciences and the Medical University of Vienna should also facilitate the training of the next generation of scientists, developers and doctors who will be able to utilise these technologies in conjunction with one another in routine clinical practice. One example of this would be the optimisation of neurosurgical planning to better determine the type of tumour, its environment and the simulation of the procedure with the help of virtual reality. In order to meet the highest international standards, the doctoral programme includes at least one stay abroad per doctoral student with international research partners. Seven international renowned cooperation partners from academia (e.g. Harvard and MIT) and industry (e.g. ICOMETRIX) have agreed to host our candidates. In addition to the positive effects for all stakeholders involved in this project, this interdisciplinary and cooperative doctoral programme will also significantly increase the proportion of medical research in Carinthia as the latest findings from Austria's largest medical research institution will be incorporated.

Multiple sclerosis is a chronic disease of the central nervous system. Some magnetic resonance imaging (MRI) markers for disease activity such as the number of Gadolinium-enhancing lesions work well to predict the conversion from clinically isolated syndrome to MS. MRI and pathological studies report iron accumulation around a subset of chronically demyelinated MS plaques forming characteristic iron ring lesions. In this longitudinal imaging study on MS patients we will analyze the presence or absence of hypointense rings around lesions in susceptibility-weighted imaging (SWI) around a subset of lesions, and in a subset of MS patients. If the presence or absence of the respective lesion types is indeed related to faster or slower atrophy development, we will be able to establish a highly practical novel imaging marker for disease progression in multiple sclerosis.

Brain iron is according to many studies related to neurodegenerative disease such as Alzheimer’s disease and Parkinson’s disease. Quantitative susceptibility mapping (QSM) and R2* mapping are promising tools to image and analyze areas of increased iron levels within the human brain by using magnetic resonance imaging (MRI). Both QSM and R2* are well established methods for isotropic deep gray matter, but the situation is more complex for white matter regions. The aim of this project is to create a 3D iron atlas and a myelin atlas of a whole human brain in order to evaluate QSM and R2* mapping. The iron atlas and the myelin map will be based on 2D histological analysis (iron and myelin staining) and the ferrozine assay will be used to calculate a quantitative iron map. In order to create a 3D map of the iron and myelin concentrations, the 2D iron and myelin stains will be reconstructed to a 3D volume referred to as atlas.

Bei diesem Projekt mit der Nuklearmedizin des Klinikum Klagenfurt handelt es sich um die Neuinstallation eines PET-CT-Gerätes. PET-CT-Geräte verbinden die Vorteile der Computertomographie und der Positronen-Emissions- Tomographie. Im Rahmen des Projektes wird ein Leitfaden zur Neuinstallation für PET-CTs erstellt. Die Bildqualität beider Geräte wird aufgrund von Messungen mit Phantomen bestimmt und verglichen. Die Anforderungen für die Installation und die Inbetriebnahme eines PET-CT-Gerätes sind sehr umfangreich (Strahlenschutz, Klimatisierung, Statik des Geräteraums, technische Qualitätssicherung usw.). Das Ziel ist einen detaillierten Einblick in diese Anforderungen und Prozesse zu bekommen. Durch das Projekt erhalten Studierende wie auch Mitarbeiterinnen direkten Zugriff auf die Prozesse einer Neuinstallation. Weiters sind auch die wissenschaftliche Weiterbildung und die Basis für klinische Projekte als wichtige Ergebnisse zu nennen.